Multinational telemedicine firm Teladoc Health Inc. closed 2021 with a narrower net loss, as the company reported growth across several business units during the period.

  • Fourth-quarter net loss narrowed to $10.985 million from $393.967 million the previous year, bringing the diluted net loss per share to $0.07 from $3.07. Revenue grew to $554.235 million from $383.321 million.
  • The company said healthcare had a ‘new normal’ following the COVID-19 pandemic with virtual solutions, with access fees revenue up 51% and visit fee revenue up 21%. Revenues from the US and international markets climbed by over 40%.
  • The full-year net loss improved to $428.793 million from $485.136 million in 2020, with the diluted net loss per share at $2.73 from $5.36. Revenue for the year jumped 86% to $2.032 billion from $1.093 billion in 2020.
  • Teladoc expects revenues between $565 million to $572 million in the first quarter and between $2.55 billion to $2.65 billion for the full year. Net loss per share for the first quarter is seen between $0.60 to $0.50, and full-year between $1.60 and $1.40.

Chief Executive Jason Gorevic said the firm will launch new services and expand into new markets in 2022. TDOC is down 2.10%.